These results indicate that Bcl-2 expression, tumor size, and cancer-associated lymphohistiocytic inflammation were the 3 significant and independent predictors of the outcome of female cats with ER+ and/or PR+ mammary carcinoma in this cohort. This evidence concerns the gene ESR1 and neoplasm.